ASHLEY REINHARDT: Open Payments
NPI 1366794125 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 19 payments from 11 companies in 2025. Trend: 2023 $40 · 2024 $192 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $138 |
| ABBVIE INC. | 4 | $88 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| PFIZER INC. | 3 | $60 |
| Novo Nordisk Inc | 2 | $35 |
| Astellas Pharma US Inc | 1 | $34 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: REJOYN, UBRELVY, LEQVIO, QULIPTA, ELIQUIS, Veozah, ENTRESTO, PREVNAR 20.
Industry payments across FL — which companies pay providers there.
